Treatment Adherence clinical trials at UC Irvine
2 research studies open to eligible people
Mi Propio Camino Intervention RCT for Blood Pressure Medication Adherence
open to eligible people ages 18 years and up
The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.
Irvine, California
Mobile Health for Adherence in Breast Cancer Patients
open to eligible people ages 18 years and up
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Orange, California and other locations
Our lead scientists for Treatment Adherence research studies include Gelareh Sadigh John Billimek, PhD.
Last updated: